TNFRSF4 and neoplasm: This suggested that the effects we observed on gene expression with RT+CpG+OX40 on day 14 after RT, while potentially critical to the in situ vaccine effect, were not likely to be the primary driver of the RT-dependent changes in the TME that enabled an anti-tumor response to CpG+OX40.